Lactose (India) Ltd

Lactose (India) Ltd (LACTOSE) is a micro-cap Healthcare company valued at ₹105 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Lactose (India) Ltd last traded at ₹101, down 4.72% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing revenue of ₹47 crore and net profit of ₹2 crore, up 18.7% and 58.0% respectively compared to the same quarter a year earlier. Promoter shares pledged reached 26.07% of promoter holding as of 2026-06-30.

Financial performance

The company's business is growing, with annual revenue rising 40.3% and net profit increasing 17.4% year-over-year. The latest quarter saw revenue and net profit both rising compared to the same quarter a year earlier, with revenue up 18.7% and net profit up 58.0%, though the net profit margin narrowed slightly to 3.7% from 4.4%.

Valuation multiples

The stock trades at 20.9 times earnings, a discount to the Healthcare median of 32.0, 1.95 times book value.

Things to watch

The stock is 22.3% below its 52-week high, and the net profit margin has narrowed by 0.7 percentage points to 3.7%. Promoter shares pledged account for 26.07% of promoter holding, which may indicate potential liquidity concerns.

Where it stands

Lactose (India) Ltd has shown strong revenue and profit growth over the past three and five years, with recent quarterly results reflecting continued expansion. The stock's distance from its 52-week high and the narrowing net profit margin are key factors to note as of the latest reporting period.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.